Tags: breast cancer


Talazoparib touted as ‘promising,’ but is it any better than a similar breast cancer drug that’s already available?


Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier


In story on texting program for chemo patients, Reuters Health keeps most study details on the DL


A study that may help reduce overtreatment of breast cancer gets solid write-up by Bloomberg


Independent viewpoint helps round out HealthDay story on impact of earlier mammograms

1 3/8/2018

USA Today rehashes PR talking points in story on at-home breast cancer gene test


‘It’s unknown whether treatment increases survival,’ AP wisely notes about new breast cancer drug

1 11/28/2017

Patient anecdote outweighs data in AP’s look at lymph node transfer surgery

1 10/16/2017

HealthDay rehashes news release in uncritical look at breast cancer screening


Bloomberg offers up balanced recap of new breast cancer therapy